πŸ‡ΊπŸ‡Έ FDA
Patent

US 8691241

Reoviruses having modified sequences

granted A61KA61K35/13A61K35/765

Quick answer

US patent 8691241 (Reoviruses having modified sequences) held by ONCOLYTICS BIOTECH INC. expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/13, A61K35/765, A61K45/06, A61P